Can a culturally smart program close the kidney transplant gap for hispanics?
NCT ID NCT03276390
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study tests a program designed to increase living donor kidney transplants among Hispanic patients with end-stage renal disease. The program provides Spanish-language education and outreach by bicultural health workers. Researchers will compare transplant rates between Hispanic and non-Hispanic white patients at two transplant centers. The goal is to reduce long-standing disparities in access to kidney transplants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Hispanic Kidney Transplant Program (HKTP)
What this could lead to
If successful, this program could reduce racial disparities in kidney transplantation and help more Hispanic patients receive a living donor kidney.
What could go wrong
The program's impact may vary across centers, and cultural factors alone may not fully address the complex barriers to living donation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESRD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- TESTING IgA Nephropathy Long-Term Follow-Up (NCT05434325)
- VasQ Device for AV Fistula in ESRD (NCT03242343)
- Kidney Transplant Decision Aid Study (NCT05879302)
- Canagliflozin for PD: Phase II Trial (NCT06913647)
- Canagliflozin for Advanced Kidney Disease (NCT05309785)
- SAVE-FistulaS: SelfWrap for AV Fistulas (NCT06001827)
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor University Medical Center
Dallas, Texas, 75246, United States
-
Houston Methodist Hospital
Houston, Texas, 77030, United States
-
Mayo Clinic Arizon
Phoenix, Arizona, 85054, United States
-
University of Colorado Denver
Denver, Colorado, 80045, United States